TAIMED BIOLOGICS INC.

 

Area: CDMO

Booth No: M732

Website: http://www.taimedbiologics.com/

 

Exhibitor Profile

 

TaiMed Biologics was formed in 2007 to realize the vision of creating a world-class, innovation-based biotechnology company that will satisfy unmet medical needs. We have vast experience in mAb development and manufacturing and successfully launched the first and only mAb for HIV treatment in US and EU (Trogarzo®).
With our massive expertise, we provide CDMO services including GMP manufacturing, process/ analytical method development, and validation to propel client's commercialization process.

 

Brands

 

TaiMed Biologics was formed in 2007 to realize the vision of creating a world-class, innovation-based biotech company to satisfy unmet medical need

 

Video

 

• 

  TaiMed Biologics: An Innovator in HIV Therapy and CDMO Service Provider

 

 

Exhibit Products

 

• 

  Antibody-Drug Conjugates, ADCs

• 

  Regulatory Affairs

• 

  cGMP Manufacturing

• 

  TMB-365

• 

  Process Development

• 

  Formulation Development

• 

  TMB-365/TMB-380 (TMB-365 and TMB-380 combination)

• 

  Analysis and Analytical Method Development

• 

  Trogarzo (Ibalizumab)

 

Exhibitor Press Release

 

• TaiMed Biologics Hosts Interactive Activities at BIO Asia 2025 to Promote HIV Awareness 2025-07-22
• TaiMed Biologics Highlights Integrated CDMO Services at BIO Asia 2025 2025-07-08
• TaiMed at BIO Asia 2025: Advancing Long-Acting HIV Therapy and Innovative ADC Platform 2025-06-24

 

 

 

back